These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21506907)

  • 1. Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics?
    Antonioli L; Fornai M; Colucci R; Tuccori M; Blandizzi C
    Expert Opin Investig Drugs; 2011 Jun; 20(6):717-21. PubMed ID: 21506907
    [No Abstract]   [Full Text] [Related]  

  • 2. Expeditious synthesis and biological evaluation of new C-6 1,2,3-triazole adenosine derivatives A1 receptor antagonists or agonists.
    Mathew SC; By Y; Berthault A; Virolleaud MA; Carrega L; Chouraqui G; Commeiras L; Condo J; Attolini M; Gaudel-Siri A; Ruf J; Rodriguez J; Parrain JL; Guieu R
    Org Biomol Chem; 2010 Sep; 8(17):3874-81. PubMed ID: 20617271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells.
    Costa MA; Barbosa A; Neto E; Sá-e-Sousa A; Freitas R; Neves JM; Magalhães-Cardoso T; Ferreirinha F; Correia-de-Sá P
    J Cell Physiol; 2011 May; 226(5):1353-66. PubMed ID: 20945394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the Development of Agonists, Antagonists and Allosteric Modulators of Adenosine Receptors.
    Deb PK
    Curr Pharm Des; 2019; 25(25):2695-2696. PubMed ID: 31603053
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting of adenosine receptors in ischemia-reperfusion injury.
    Laubach VE; French BA; Okusa MD
    Expert Opin Ther Targets; 2011 Jan; 15(1):103-18. PubMed ID: 21110787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular adenosine receptors; potential clinical applications.
    Ho MF; Rose'Meyer RB
    Curr Vasc Pharmacol; 2013 May; 11(3):327-37. PubMed ID: 22724462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways.
    Agarwal R; Agarwal P
    Expert Opin Ther Targets; 2014 May; 18(5):527-39. PubMed ID: 24579961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P1 (adenosine) purinoceptor assays.
    Mustafa SJ; Ansari HR; Abebe W
    Curr Protoc Pharmacol; 2009 Jun; Chapter 4():Unit 4.7. PubMed ID: 22294395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of adenosine receptors in rheumatoid arthritis.
    Varani K; Padovan M; Govoni M; Vincenzi F; Trotta F; Borea PA
    Autoimmun Rev; 2010 Dec; 10(2):61-4. PubMed ID: 20691813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine receptors and inflammation.
    Blackburn MR; Vance CO; Morschl E; Wilson CN
    Handb Exp Pharmacol; 2009; (193):215-69. PubMed ID: 19639284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine receptor desensitization and trafficking.
    Mundell S; Kelly E
    Biochim Biophys Acta; 2011 May; 1808(5):1319-28. PubMed ID: 20550943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety issues of compounds acting on adenosinergic signalling.
    Schmidt J; Ferk P
    J Pharm Pharmacol; 2017 Jul; 69(7):790-806. PubMed ID: 28397249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms.
    Jespers W; Schiedel AC; Heitman LH; Cooke RM; Kleene L; van Westen GJP; Gloriam DE; Müller CE; Sotelo E; Gutiérrez-de-Terán H
    Trends Pharmacol Sci; 2018 Jan; 39(1):75-89. PubMed ID: 29203139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of adenosine receptors on immunoglobulin production by human peripheral blood B lymphocytes.
    Sakowicz-Burkiewicz M; Kocbuch K; Grden M; Maciejewska I; Szutowicz A; Pawelczyk T
    J Physiol Pharmacol; 2012 Dec; 63(6):661-8. PubMed ID: 23388482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.
    Akkari R; Burbiel JC; Hockemeyer J; Müller CE
    Curr Top Med Chem; 2006; 6(13):1375-99. PubMed ID: 16918456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
    Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
    Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of adenosine A2A receptors.
    Ongini E; Fredholm BB
    Trends Pharmacol Sci; 1996 Oct; 17(10):364-72. PubMed ID: 8979771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adenosine receptor agonists and antagonists on transport of adenosine in bovine heart microvascular endothelial cells.
    Barankiewicz J
    Adv Exp Med Biol; 2000; 486():227-31. PubMed ID: 11783489
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic potency of pharmacological adenosine receptor agonist/antagonist in angiogenesis, current status and perspectives.
    Bahreyni A; Khazaei M; Rajabian M; Ryzhikov M; Avan A; Hassanian SM
    J Pharm Pharmacol; 2018 Feb; 70(2):191-196. PubMed ID: 29057476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists.
    Rodríguez-Borges JE; García-Mera X; Balo MC; Brea J; Caamaño O; Fernández F; López C; Loza MI; Nieto MI
    Bioorg Med Chem; 2010 Mar; 18(5):2001-9. PubMed ID: 20137957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.